Unichem Laboratories Ltd. — Major Shareholding Notification 2023

Sep 1, 2023

August 31, 2023

Pradeep Bhandari Company Secretary & Compliance Officer Unichem Laboratories Limited Unichem Bhavan, S V Road, Prabhat Estate, Jogeshwari (West) Mumbai, Maharashtra, 400102 Tel. No. - 022-66888333 Fax No. - 022-26784391

Dear Sir.

Sub: Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

We refer to our letter dated September 18, 2019 wherein we had mentioned that as on September 17, 2019, the aggregate holding of the Schemes of HDFC Mutual Fund in "Unichem Laboratories Limited." ("The Company") was 5.34% of the paid up equity share capital of the Company (Paid up Equity Share Capital being Rs. 14,08,11,500/- comprising 7,04,05,750 Equity Shares of Rs. 2/- each).

Further, in accordance with the captioned regulation and other applicable laws / regulations, if any, we wish to inform you that there has been an increase in the shareholding of the Company by the Schemes of HDFC Mutual Fund by 2.07% as of August 30, 2023. As on August 30, 2023 the aggregate holding of the Schemes of HDFC Mutual Fund in the Company is 7.41% of the paid up equity share capital of the Company (Paid up Equity Share Capital being Rs. 14,08,11,500/- comprising 7,04,05,750 Equity Shares of Rs. 2/- each).

As per Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 please find enclosed the details of change in the shareholding in the prescribed format enclosed as Annexure 1.

Kindly acknowledge receipt of the same.

Thanking you, Yours faithfully, For HDFC Asset Management Company Limited

Dinesh Bhakade Associate Vice President - Compliance

Encl: As above

Listing Department
BSE Limited
Phiroze Jeejeebhoy Towers
Dalal Street,
Mumbai - 400 001.
Fax: 022-2272 3121

ÿ.

HDFC Asset Management Company Limited CIN No.: L65991MH1999PLC123027

Annexure-1

Disclosures under Regulation 29(2) of MUTUAL FUND
SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 BHAROSA APNO KA

Name of the Target Company (TC)	Unichem Laboratories Ltd.
Name(s) of the acquirer and Persons	HDFC Mutual Fund:
Acting in Concert (PAC) with the		HDFC Trustee Company Limited A/c -
acquirer
	HDFC Small Cap Fund
belongs the acquirer to Whether	NO
Promoter/ Promoter group
Name(s) of the Stock Exchange(s) where	BSE Limited
the shares of TC are Listed	National Stock Exchange of India Limited
Details of the acquisition / disposal as	Number	% w.r.t. total	$\frac{0}{0}$ total w.r.t.
follows		share/ voting	share/ diluted
		capital	voting capital of
		wherever applicable (*)	the $TC$ $(**)$
acquisition under the Before
consideration, holding of:
a) Shares carrying voting rights	37,58,559	5.34	N.A
b) Shares in the nature of encumbrance	$\mathbf{0}$	$\overline{0}$	N.A
(pledge/ lien/non-disposal undertaking/
others)
c) Voting rights (VR) otherwise than by	$\overline{0}$	0	N.A
shares
d) Warrants/ convertible securities/ any	$\mathbf{O}$	0	N.A
other instrument that entitles the acquirer
to receive shares carrying voting rights in the TC (specify holding in each category)
$e)$ Total (a+b+c+d)	37,58,559	5.34	N.A
Details of Acquisition/Sale:
rights voting Shares carrying a)	14,55,954	2.07	N.A
acquired/sold
b) VRs acquired /sold otherwise than by	$\overline{0}$	$\overline{0}$	N.A
shares
c) Warrants/convertible securities/any	$\mathbf 0$	$\overline{0}$	N.A
other instrument that entitles the acquirer
to receive shares carrying voting rights in
the TC (specify holding in each category) acquired/sold
d) Shares encumbered/invoked/released	0	$\overline{0}$	N.A
by the acquirer
$e)$ Total (a+b+c+/-d)	14,55,954	2.07	N.A
After the Acquisition/Sale, holding of:
a) Shares carrying voting rights	52, 14, 513 0	7.41 $\Omega$	N.A N.A
b) Shares encumbered with the acquirer	0	$\overline{0}$	N.A
c) VRs otherwise than by shares

Annexure-1

Disclosures under Regulation 29(2) of

SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 BHAROS,

d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition.	0	0	N.A
$e)$ Total (a+b+c+d)	52, 14, 513	7.41	N.A
Mode of acquisition/sale (e.g. open market / off-market / public issue / rights issue / preferential allotment / inter-se transfer etc).	Open Market
Date of acquisition/sale of shares / VR or date of receipt of intimation of allotment of shares, whichever is applicable	August 30, 2023
Equity share capital / total voting capital of the TC before the said acquisition/sale	Rs. 14,08,11,500/- comprising 7,04,05,750 equity shares of Rs. 2/- each.
Equity share capital/ total voting capital of the TC after the said acquisition/sale	Rs. 14,08,11,500/- comprising 7,04,05,750 equity shares of Rs. 2/- each.
Total diluted share/voting capital of the TC after the said acquisition/sale	N.A.	Commercial

(*) Total share capital/voting capital has been taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement. Ň

(**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.

For HDFC Asset Management Company Limited

(Investment Manager for the Schemes of HDFC Mutual Fund)

Dinesh Bhakade Associate Vice President - Compliance

Place: Mumbai Date: August 31, 2023

iť